References
- Susanibar-Adaniya S, Barta SK. 2021 Update on Diffuse large B cell
lymphoma: A review of current data and potential applications on risk
stratification and management. Am J Hematol.
2021;96(5):617-629. doi:10.1002/ajh.26151
- Li S, Young KH, Medeiros LJ. Diffuse large B-cell lymphoma.Pathology. 2018;50(1):74-87. doi:10.1016/j.pathol.2017.09.006
- Friedberg JW, Fisher RI. Diffuse large B-cell lymphoma. Hematol
Oncol Clin North Am. 2008;22(5):941-ix. doi:10.1016/j.hoc.2008.07.002
- Nedomova R, Papajik T, Prochazka V, Indrak K, Jarosova M. Cytogenetics
and molecular cytogenetics in diffuse large B-cell lymphoma
(DLBCL). Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub.
2013;157(3):239-247. doi:10.5507/bp.2012.085
- Solimando AG, Annese T, Tamma R, et al. New Insights into Diffuse
Large B-Cell Lymphoma Pathobiology. Cancers (Basel).
2020;12(7):1869. Published 2020 Jul 11. doi:10.3390/cancers12071869
- Padala SA, Kallam A. Diffuse Large B Cell Lymphoma. In:StatPearls. Treasure Island (FL): StatPearls Publishing; August
2, 2021.
- Howell JM, Auer-Grzesiak I, Zhang J, Andrews CN, Stewart D, Urbanski
SJ. Increasing incidence rates, distribution and histological
characteristics of primary gastrointestinal non-Hodgkin lymphoma in a
North American population. Can J Gastroenterol.
2012;26(7):452-456. doi:10.1155/2012/480160
- Lo Re G, Federica V, Midiri F, et al. Radiological Features of
Gastrointestinal Lymphoma [published correction appears in
Gastroenterol Res Pract. 2016;2016:9742102]. Gastroenterol Res
Pract. 2016;2016:2498143. doi:10.1155/2016/2498143
- Shirwaikar Thomas A, Schwartz M, Quigley E. Gastrointestinal lymphoma:
the new mimic. BMJ Open Gastroenterol. 2019;6(1):e000320.
Published 2019 Sep 13. doi:10.1136/bmjgast-2019-000320
- Lodhi HT, Hussain Q, Munir A, Zafar F, Khan ZH. Primary
Gastrointestinal Diffuse Large B-cell Lymphoma. Cureus.
2018;10(9):e3258. Published 2018 Sep 5. doi:10.7759/cureus.3258
- Ghai S, Pattison J, Ghai S, O’Malley ME, Khalili K, Stephens M.
Primary gastrointestinal lymphoma: spectrum of imaging findings with
pathologic correlation. Radiographics. 2007;27(5):1371-1388.
doi:10.1148/rg.275065151
- Pfreundschuh M. How I treat elderly patients with diffuse large B-cell
lymphoma. Blood. 2010;116(24):5103-5110.
doi:10.1182/blood-2010-07-259333
- Liu Y, Barta SK. Diffuse large B-cell lymphoma: 2019 update on
diagnosis, risk stratification, and treatment. Am J Hematol.
2019;94(5):604-616. doi:10.1002/ajh.25460
- Zaarour M, Busack C, Munker R. Obstructing Duodenal Diffuse Large
B-cell Lymphoma with Peritoneal Lymphomatosis with Exceptional
Response to R-CHOP. Cureus. 2019;11(5):e4621. Published 2019
May 8. doi:10.7759/cureus.4621
- Pejša V, Prka Ž, Lucijanić M, et al. Rituximab with dose-adjusted
EPOCH as first-line treatment in patients with highly aggressive
diffuse large B-cell lymphoma and autologous stem cell transplantation
in selected patients. Croat Med J. 2017;58(1):40-48.
doi:10.3325/cmj.2017.58.40
- Sussman J, Varela NP, Cheung M, et al. Follow-up care for survivors of
lymphoma who have received curative-intent treatment. Curr
Oncol. 2016;23(5):e499-e513. doi:10.3747/co.23.3265